"One DEA Schedule I laboratory registration approved. FDA INDs granted. Orphan Drug Designation awarded. Yet the cultivation application remains unresolved as patients continue to wait. This is ...

UPPSALA, SE / ACCESS Newswire / May 27, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that its TetraGraph® neuromuscular monitoring system has received an additional FDA Class II ...

A leading alcohol‑reduction specialist credits advances in moderation therapies for a decline in the number of UK ...

Delphia Therapeutics, Inc. (Delphia), a biopharmaceutical company pioneering an innovative new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to ...

Global AI in Life Science Market OverviewThe global AI in life science market is witnessing exceptional growth and is ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, ...

OverviewThe global orthopedic implants market is poised for steady expansion, with an estimated CAGR of around 4% over the ...

Study Topline results will be released around the end of Q2 2026BIA 28-6156 is being developed as a potential first-in-class ...

Creative Biogene is a dedicated research solutions provider focused on developing cutting-edge platforms for cancer therapy and preclinical studies. The team of seasoned scientists, bioinformatics ...

Thousands of validated payer IT users and provider finance, business office, RCM and reimbursement professionals contribute category-specific evaluations across 90 healthcare technology and managed ...

Company discusses AI-assisted body-map monitoring architecture and long-term imaging technology development initiatives MESA, AZ / ACCESS Newswire / May 28, 2026 / Medical Care Technologies Inc. (OTC ...

Global Medical Devices Outsourcing Market OverviewThe global medical devices outsourcing market is witnessing remarkable ...